welcome
Reuters

Reuters

Health

Health

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

Reuters
Summary
Nutrition label

79% Informative

J&J said it is seeking a preliminary injunction for Samsung Bioepis' close copy of Stelara .

The company, along with partner Sandoz , said earlier on Monday that its biosimilar Pyzchiva is now available in the United States .

Teva Pharmaceuticals and Alvotech last Friday launched Selarsdi , a biosimilar to the autoimmune drug.

At least six close copies are expected to launch in the U.S. this year .

VR Score

85

Informative language

88

Neutral language

80

Article tone

formal

Language

English

Language complexity

73

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links

Small business owner?

Otherweb launches Autoblogger—a revolutionary way to bring more leads to any small business, using the power of AI.